- Home
- KNSA vs CDP Comparison
KNSA vs CDP Comparison
Compare KNSA & CDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | CDP |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.6B |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | KNSA | CDP |
|---|---|---|
| Price | $47.48 | $32.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $53.71 | $33.38 |
| AVG Volume (30 Days) | 445.1K | ★ 1.2M |
| Earning Date | 04-03-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.85% |
| EPS Growth | N/A | ★ 283.58 |
| EPS | 0.57 | ★ 1.01 |
| Revenue | $423,239,000.00 | ★ $753,267,000.00 |
| Revenue This Year | $62.99 | $2.14 |
| Revenue Next Year | $33.30 | $3.12 |
| P/E Ratio | $82.68 | ★ $31.31 |
| Revenue Growth | ★ 56.60 | 9.97 |
| 52 Week Low | $18.26 | $23.92 |
| 52 Week High | $47.51 | $32.78 |
Technical Indicators
Market Signals| Indicator | KNSA | CDP |
|---|---|---|
| Relative Strength Index (RSI) | 67.87 | 60.08 |
| Support Level | $43.55 | $31.32 |
| Resistance Level | $47.51 | $31.91 |
| Average True Range (ATR) | 1.67 | 0.67 |
| MACD | 0.26 | -0.06 |
| Stochastic Oscillator | 95.93 | 58.12 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About CDP COPT Defense Properties of Beneficial Interest
COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.